HEADER TRANSFERASE 11-FEB-04 1VA5 TITLE ANTIGEN 85C WITH OCTYLTHIOGLUCOSIDE IN ACTIVE SITE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTIGEN 85-C; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.3.1.-; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: FBPC2; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET29 KEYWDS ALPHA-BETA HYDROLASE, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE KEYWDS 2 INITIATIVE, TB STRUCTURAL GENOMICS CONSORTIUM, TBSGC, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.R.RONNING,V.VISSA,G.S.BESRA,J.T.BELISLE,J.C.SACCHETTINI,TB AUTHOR 2 STRUCTURAL GENOMICS CONSORTIUM (TBSGC) REVDAT 6 25-OCT-23 1VA5 1 HETSYN REVDAT 5 29-JUL-20 1VA5 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 SITE REVDAT 4 24-FEB-09 1VA5 1 VERSN REVDAT 3 01-FEB-05 1VA5 1 AUTHOR KEYWDS REMARK REVDAT 2 07-SEP-04 1VA5 1 JRNL REVDAT 1 06-JUL-04 1VA5 0 JRNL AUTH D.R.RONNING,V.VISSA,G.S.BESRA,J.T.BELISLE,J.C.SACCHETTINI JRNL TITL MYCOBACTERIUM TUBERCULOSIS ANTIGEN 85A AND 85C STRUCTURES JRNL TITL 2 CONFIRM BINDING ORIENTATION AND CONSERVED SUBSTRATE JRNL TITL 3 SPECIFICITY JRNL REF J.BIOL.CHEM. V. 279 36771 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 15192106 JRNL DOI 10.1074/JBC.M400811200 REMARK 2 REMARK 2 RESOLUTION. 2.02 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.02 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 507000.610 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 43409 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2172 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.02 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6561 REMARK 3 BIN R VALUE (WORKING SET) : 0.1830 REMARK 3 BIN FREE R VALUE : 0.2180 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 318 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4406 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 252 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.75000 REMARK 3 B22 (A**2) : -3.91000 REMARK 3 B33 (A**2) : 1.16000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.74000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM SIGMAA (A) : 0.04 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.10 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.920 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.140 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.680 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.770 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.510 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 49.99 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : THIO.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : THIO.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1VA5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-FEB-04. REMARK 100 THE DEPOSITION ID IS D_1000006398. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-AUG-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI MIRROR + NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MACSCIENCE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44080 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.020 REMARK 200 RESOLUTION RANGE LOW (A) : 38.720 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04200 REMARK 200 FOR THE DATA SET : 17.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.02 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.11400 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1DZQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: OCTYLTHIOGLUCOSIDE, SODIUM ACETATE, REMARK 280 IMIDAZOLE, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 72.40900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.05850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 72.40900 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.05850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 283 REMARK 465 THR A 284 REMARK 465 PRO A 285 REMARK 465 PRO A 286 REMARK 465 ALA A 287 REMARK 465 ALA A 288 REMARK 465 PRO A 289 REMARK 465 ALA A 290 REMARK 465 ALA A 291 REMARK 465 PRO A 292 REMARK 465 ALA A 293 REMARK 465 ALA A 294 REMARK 465 LEU A 295 REMARK 465 GLY A 296 REMARK 465 HIS A 297 REMARK 465 HIS A 298 REMARK 465 HIS A 299 REMARK 465 HIS A 300 REMARK 465 HIS A 301 REMARK 465 HIS A 302 REMARK 465 ALA B 283 REMARK 465 THR B 284 REMARK 465 PRO B 285 REMARK 465 PRO B 286 REMARK 465 ALA B 287 REMARK 465 ALA B 288 REMARK 465 PRO B 289 REMARK 465 ALA B 290 REMARK 465 ALA B 291 REMARK 465 PRO B 292 REMARK 465 ALA B 293 REMARK 465 ALA B 294 REMARK 465 LEU B 295 REMARK 465 GLY B 296 REMARK 465 HIS B 297 REMARK 465 HIS B 298 REMARK 465 HIS B 299 REMARK 465 HIS B 300 REMARK 465 HIS B 301 REMARK 465 HIS B 302 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 4 C - N - CA ANGL. DEV. = 12.2 DEGREES REMARK 500 PRO A 4 C - N - CD ANGL. DEV. = -16.1 DEGREES REMARK 500 GLY A 5 N - CA - C ANGL. DEV. = -16.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 1 141.51 161.03 REMARK 500 SER A 2 -126.18 -64.34 REMARK 500 ARG A 3 -66.42 175.95 REMARK 500 PRO A 4 160.77 -14.37 REMARK 500 ARG A 41 32.38 -90.17 REMARK 500 PRO A 54 31.07 -91.60 REMARK 500 PHE A 76 15.74 59.83 REMARK 500 SER A 86 -53.47 175.05 REMARK 500 ARG A 101 -60.71 -131.35 REMARK 500 SER A 124 -124.20 50.87 REMARK 500 ASN A 152 55.40 -147.23 REMARK 500 SER A 169 77.29 -103.65 REMARK 500 SER A 215 -169.20 -121.06 REMARK 500 ARG A 248 17.45 -148.61 REMARK 500 PRO A 256 44.20 -79.68 REMARK 500 PHE B 1 -29.90 -176.35 REMARK 500 SER B 2 -76.02 105.86 REMARK 500 ARG B 3 60.88 17.66 REMARK 500 ARG B 41 31.93 -90.78 REMARK 500 PRO B 54 32.48 -93.75 REMARK 500 PHE B 76 17.26 59.31 REMARK 500 SER B 86 -52.65 172.72 REMARK 500 ARG B 101 -60.37 -130.06 REMARK 500 SER B 124 -122.78 51.86 REMARK 500 ASN B 152 55.15 -149.04 REMARK 500 SER B 169 77.82 -104.41 REMARK 500 MET B 177 -72.07 -78.23 REMARK 500 SER B 215 -163.69 -109.10 REMARK 500 ARG B 248 24.14 -144.99 REMARK 500 PRO B 256 43.56 -80.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DQY RELATED DB: PDB REMARK 900 SAME PROTEIN WITH COVALENT INHIBITOR REMARK 900 RELATED ID: 1DQZ RELATED DB: PDB REMARK 900 SAME PROTEIN WITH NOTHING BOUND REMARK 900 RELATED ID: 1F0N RELATED DB: PDB REMARK 900 HOMOLOGOUS PROTEIN REMARK 900 RELATED ID: 1F0P RELATED DB: PDB REMARK 900 HOMOLOGOUS PROTEIN WITH TREHALOSE BOUND REMARK 900 RELATED ID: RV0129C RELATED DB: TARGETDB DBREF 1VA5 A 1 294 UNP P0A4V4 A85C_MYCTU 47 340 DBREF 1VA5 B 1 294 UNP P0A4V4 A85C_MYCTU 47 340 SEQADV 1VA5 MET A 0 UNP P0A4V4 INITIATING METHIONINE SEQADV 1VA5 LEU A 295 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 GLY A 296 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 HIS A 297 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 HIS A 298 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 HIS A 299 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 HIS A 300 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 HIS A 301 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 HIS A 302 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 MET B 0 UNP P0A4V4 INITIATING METHIONINE SEQADV 1VA5 LEU B 295 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 GLY B 296 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 HIS B 297 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 HIS B 298 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 HIS B 299 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 HIS B 300 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 HIS B 301 UNP P0A4V4 EXPRESSION TAG SEQADV 1VA5 HIS B 302 UNP P0A4V4 EXPRESSION TAG SEQRES 1 A 303 MET PHE SER ARG PRO GLY LEU PRO VAL GLU TYR LEU GLN SEQRES 2 A 303 VAL PRO SER ALA SER MET GLY ARG ASP ILE LYS VAL GLN SEQRES 3 A 303 PHE GLN GLY GLY GLY PRO HIS ALA VAL TYR LEU LEU ASP SEQRES 4 A 303 GLY LEU ARG ALA GLN ASP ASP TYR ASN GLY TRP ASP ILE SEQRES 5 A 303 ASN THR PRO ALA PHE GLU GLU TYR TYR GLN SER GLY LEU SEQRES 6 A 303 SER VAL ILE MET PRO VAL GLY GLY GLN SER SER PHE TYR SEQRES 7 A 303 THR ASP TRP TYR GLN PRO SER GLN SER ASN GLY GLN ASN SEQRES 8 A 303 TYR THR TYR LYS TRP GLU THR PHE LEU THR ARG GLU MET SEQRES 9 A 303 PRO ALA TRP LEU GLN ALA ASN LYS GLY VAL SER PRO THR SEQRES 10 A 303 GLY ASN ALA ALA VAL GLY LEU SER MET SER GLY GLY SER SEQRES 11 A 303 ALA LEU ILE LEU ALA ALA TYR TYR PRO GLN GLN PHE PRO SEQRES 12 A 303 TYR ALA ALA SER LEU SER GLY PHE LEU ASN PRO SER GLU SEQRES 13 A 303 GLY TRP TRP PRO THR LEU ILE GLY LEU ALA MET ASN ASP SEQRES 14 A 303 SER GLY GLY TYR ASN ALA ASN SER MET TRP GLY PRO SER SEQRES 15 A 303 SER ASP PRO ALA TRP LYS ARG ASN ASP PRO MET VAL GLN SEQRES 16 A 303 ILE PRO ARG LEU VAL ALA ASN ASN THR ARG ILE TRP VAL SEQRES 17 A 303 TYR CYS GLY ASN GLY THR PRO SER ASP LEU GLY GLY ASP SEQRES 18 A 303 ASN ILE PRO ALA LYS PHE LEU GLU GLY LEU THR LEU ARG SEQRES 19 A 303 THR ASN GLN THR PHE ARG ASP THR TYR ALA ALA ASP GLY SEQRES 20 A 303 GLY ARG ASN GLY VAL PHE ASN PHE PRO PRO ASN GLY THR SEQRES 21 A 303 HIS SER TRP PRO TYR TRP ASN GLU GLN LEU VAL ALA MET SEQRES 22 A 303 LYS ALA ASP ILE GLN HIS VAL LEU ASN GLY ALA THR PRO SEQRES 23 A 303 PRO ALA ALA PRO ALA ALA PRO ALA ALA LEU GLY HIS HIS SEQRES 24 A 303 HIS HIS HIS HIS SEQRES 1 B 303 MET PHE SER ARG PRO GLY LEU PRO VAL GLU TYR LEU GLN SEQRES 2 B 303 VAL PRO SER ALA SER MET GLY ARG ASP ILE LYS VAL GLN SEQRES 3 B 303 PHE GLN GLY GLY GLY PRO HIS ALA VAL TYR LEU LEU ASP SEQRES 4 B 303 GLY LEU ARG ALA GLN ASP ASP TYR ASN GLY TRP ASP ILE SEQRES 5 B 303 ASN THR PRO ALA PHE GLU GLU TYR TYR GLN SER GLY LEU SEQRES 6 B 303 SER VAL ILE MET PRO VAL GLY GLY GLN SER SER PHE TYR SEQRES 7 B 303 THR ASP TRP TYR GLN PRO SER GLN SER ASN GLY GLN ASN SEQRES 8 B 303 TYR THR TYR LYS TRP GLU THR PHE LEU THR ARG GLU MET SEQRES 9 B 303 PRO ALA TRP LEU GLN ALA ASN LYS GLY VAL SER PRO THR SEQRES 10 B 303 GLY ASN ALA ALA VAL GLY LEU SER MET SER GLY GLY SER SEQRES 11 B 303 ALA LEU ILE LEU ALA ALA TYR TYR PRO GLN GLN PHE PRO SEQRES 12 B 303 TYR ALA ALA SER LEU SER GLY PHE LEU ASN PRO SER GLU SEQRES 13 B 303 GLY TRP TRP PRO THR LEU ILE GLY LEU ALA MET ASN ASP SEQRES 14 B 303 SER GLY GLY TYR ASN ALA ASN SER MET TRP GLY PRO SER SEQRES 15 B 303 SER ASP PRO ALA TRP LYS ARG ASN ASP PRO MET VAL GLN SEQRES 16 B 303 ILE PRO ARG LEU VAL ALA ASN ASN THR ARG ILE TRP VAL SEQRES 17 B 303 TYR CYS GLY ASN GLY THR PRO SER ASP LEU GLY GLY ASP SEQRES 18 B 303 ASN ILE PRO ALA LYS PHE LEU GLU GLY LEU THR LEU ARG SEQRES 19 B 303 THR ASN GLN THR PHE ARG ASP THR TYR ALA ALA ASP GLY SEQRES 20 B 303 GLY ARG ASN GLY VAL PHE ASN PHE PRO PRO ASN GLY THR SEQRES 21 B 303 HIS SER TRP PRO TYR TRP ASN GLU GLN LEU VAL ALA MET SEQRES 22 B 303 LYS ALA ASP ILE GLN HIS VAL LEU ASN GLY ALA THR PRO SEQRES 23 B 303 PRO ALA ALA PRO ALA ALA PRO ALA ALA LEU GLY HIS HIS SEQRES 24 B 303 HIS HIS HIS HIS HET SOG A1001 20 HET SOG A1003 20 HET SOG B1002 20 HET SOG B1004 20 HETNAM SOG OCTYL 1-THIO-BETA-D-GLUCOPYRANOSIDE HETSYN SOG 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5- HETSYN 2 SOG TRIOL; 1-S-OCTYL-BETA-D-THIOGLUCOSIDE; OCTYL 1-THIO- HETSYN 3 SOG BETA-D-GLUCOSIDE; OCTYL 1-THIO-D-GLUCOSIDE; OCTYL 1- HETSYN 4 SOG THIO-GLUCOSIDE FORMUL 3 SOG 4(C14 H28 O5 S) FORMUL 7 HOH *252(H2 O) HELIX 1 1 ASN A 47 THR A 53 1 7 HELIX 2 2 PRO A 54 TYR A 60 1 7 HELIX 3 3 LYS A 94 ARG A 101 1 8 HELIX 4 4 ARG A 101 GLY A 112 1 12 HELIX 5 5 SER A 124 TYR A 137 1 14 HELIX 6 6 TRP A 157 SER A 169 1 13 HELIX 7 7 ASN A 173 GLY A 179 1 7 HELIX 8 8 ASP A 183 ASN A 189 1 7 HELIX 9 9 GLN A 194 ASN A 202 1 9 HELIX 10 10 ASN A 221 ASP A 245 1 25 HELIX 11 11 SER A 261 GLY A 282 1 22 HELIX 12 12 ASN B 47 THR B 53 1 7 HELIX 13 13 PRO B 54 TYR B 60 1 7 HELIX 14 14 LYS B 94 ARG B 101 1 8 HELIX 15 15 ARG B 101 GLY B 112 1 12 HELIX 16 16 SER B 124 TYR B 137 1 14 HELIX 17 17 TRP B 157 SER B 169 1 13 HELIX 18 18 ASN B 173 GLY B 179 1 7 HELIX 19 19 PRO B 184 ASN B 189 1 6 HELIX 20 20 GLN B 194 ASN B 201 1 8 HELIX 21 21 ASN B 221 ASP B 245 1 25 HELIX 22 22 SER B 261 GLY B 282 1 22 SHEET 1 A 8 VAL A 8 SER A 15 0 SHEET 2 A 8 ARG A 20 GLN A 27 -1 O PHE A 26 N GLU A 9 SHEET 3 A 8 SER A 65 PRO A 69 -1 O MET A 68 N GLN A 25 SHEET 4 A 8 ALA A 33 LEU A 36 1 N LEU A 36 O ILE A 67 SHEET 5 A 8 ALA A 119 LEU A 123 1 O ALA A 119 N TYR A 35 SHEET 6 A 8 TYR A 143 LEU A 147 1 O ALA A 145 N ALA A 120 SHEET 7 A 8 ARG A 204 TYR A 208 1 O TYR A 208 N SER A 146 SHEET 8 A 8 GLY A 250 ASN A 253 1 O VAL A 251 N VAL A 207 SHEET 1 B 8 VAL B 8 SER B 15 0 SHEET 2 B 8 ARG B 20 GLN B 27 -1 O PHE B 26 N GLU B 9 SHEET 3 B 8 SER B 65 PRO B 69 -1 O MET B 68 N GLN B 25 SHEET 4 B 8 ALA B 33 LEU B 36 1 N LEU B 36 O ILE B 67 SHEET 5 B 8 ALA B 119 LEU B 123 1 O ALA B 119 N TYR B 35 SHEET 6 B 8 TYR B 143 LEU B 147 1 O ALA B 145 N ALA B 120 SHEET 7 B 8 ARG B 204 TYR B 208 1 O TYR B 208 N SER B 146 SHEET 8 B 8 GLY B 250 ASN B 253 1 O VAL B 251 N VAL B 207 CRYST1 144.818 68.117 82.281 90.00 119.60 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006905 0.000000 0.003923 0.00000 SCALE2 0.000000 0.014681 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013978 0.00000